5T33 Multiple Myeloma idiotype (5T33MM Id)

The idiotype of murine 5T33 Multiple Myeloma (MM) cells consists of the unique antigenic determinants (idiotopes) located within the variable regions of the monoclonal immunoglobulin produced by the 5T33MM malignant clone [1, 4]. In the 5T33MM murine model, which is a syngeneic and immunocompetent model for human multiple myeloma, this paraprotein is specifically an IgG2b kappa antibody [10, 14]. Because the idiotype is exclusive to the tumor cells, it acts as a highly specific tumor-associated antigen (TAA) that can be targeted without affecting healthy B cells or plasma cells [4, 13]. Preclinical research utilizing the 5T33 model has explored several therapeutic modalities, including idiotype-pulsed dendritic cell vaccines, DNA vaccines, and anti-idiotypic single-domain antibodies (VHHs) for targeted radionuclide therapy [1, 2, 3]. These interventions aim to either stimulate a robust T-cell mediated immune response against the myeloma cells or deliver cytotoxic payloads directly to the tumor [4, 6]. While the 5T33 idiotype is a powerful tool for studying targeted therapy, its clinical translation is limited by the inherent requirement for personalized agent production and the potential for the tumor to evolve idiotype-negative sub-clones [1, 13].

Other names

5T33 idiotype5T33MM idiotype5T33 paraprotein idiotypeIdiotype of murine 5T33 MM cells5T33 monoclonal immunoglobulin

Induces tumor-specific immune responses or direct cell killing by targeting the unique variable region (idiotype) of the monoclonal immunoglobulin expressed on the surface of or secreted by 5T33MM cells [1, 4, 6].